Search Results - "d’Alteroche, Louis"
-
1
Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients
Published in The New England journal of medicine (20-03-2014)“…Hepatitis E virus may cause chronic infection in certain patients, such as those who are immunocompromised. In this report from France involving 59 solid-organ…”
Get full text
Journal Article -
2
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial
Published in Annals of internal medicine (01-05-2021)“…The efficacy of rifaximin in the secondary prevention of overt hepatic encephalopathy (HE) is well documented, but its effectiveness in preventing a first…”
Get full text
Journal Article -
3
High Diagnostic Value of Transient Elastography for Advanced Fibrosis and Cirrhosis in Patients With Chronic Hepatitis Delta
Published in Clinical gastroenterology and hepatology (30-08-2024)“…Liver biopsy remains the gold standard for fibrosis staging in patients with chronic hepatitis delta (CHD). Here, we comparatively evaluated the performance of…”
Get full text
Journal Article -
4
Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
Published in JHEP reports (01-01-2022)“…Reinforced hepatocellular carcinoma (HCC) surveillance using magnetic resonance imaging (MRI) could increase early tumour detection but faces…”
Get full text
Journal Article -
5
Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation
Published in The Journal of heart and lung transplantation (01-07-2011)“…Hepatitis E virus (HEV) is an emerging problem amongst transplant recipients. We report a patient with chronic HEV hepatitis after a heart transplant. The…”
Get full text
Journal Article -
6
Sequence and Functional Analysis of the Envelope Glycoproteins of Hepatitis C Virus Variants Selectively Transmitted to a New Host
Published in Journal of Virology (01-12-2013)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
7
Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort
Published in Journal of hepatology (01-03-2023)“…The harmful impact of heavy alcohol consumption and recurrence in patients with alcohol-related cirrhosis is long-established, although this is based on old…”
Get full text
Journal Article -
8
Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis
Published in Journal of hepatology (01-03-2023)“…Identifying individuals at higher risk of developing hepatocellular carcinoma (HCC) is pivotal to improve the performance of surveillance strategies. Herein,…”
Get full text
Journal Article -
9
Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis
Published in PloS one (29-03-2012)“…Most clinical studies suggest that the prevalence and severity of liver steatosis are higher in patients infected with hepatitis C virus (HCV) genotype 3 than…”
Get full text
Journal Article -
10
Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis
Published in Journal of hepatology (01-01-2006)“…Ophthalmologic side effects have been reported during interferon therapy, particularly retinal lesions and neurovisual impairment. The aim of this prospective…”
Get full text
Journal Article -
11
Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: A randomized controlled trial
Published in Journal of hepatology (01-05-2014)“…Background & Aims The first studies comparing covered stents (CS) and bare stents (BS) to achieve Transjugular Intrahepatic Portosystemic Shunt (TIPS) were in…”
Get full text
Journal Article -
12
Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension
Published in European journal of gastroenterology & hepatology (01-05-2018)“…BACKGROUNDTransjugular intrahepatic portosystemic shunt (TIPS) is considered to be well suited for the treatment of noncirrhotic portal hypertension (NCPHT)…”
Get full text
Journal Article -
13
Continuum of hepatitis C care in France: A 20-year cohort study
Published in PloS one (29-08-2017)“…Hepatitis C virus (HCV)-infected patients require a specific continuum of care (CoC) from HCV screening to treatment. We assessed CoC of HCV-infected patients…”
Get full text
Journal Article -
14
Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation
Published in Clinical gastroenterology and hepatology (01-11-2015)“…Background & Aims Fibrosing cholestatic hepatitis (FCH) is a life-threating disorder that develops in patients with recurrent hepatitis C virus (HCV) infection…”
Get full text
Journal Article -
15
Management of splanchnic vein thrombosis
Published in JHEP reports (01-04-2023)“…The expression splanchnic vein thrombosis encompasses Budd-Chiari syndrome and portal vein thrombosis. These disorders have common characteristics: they are…”
Get full text
Journal Article -
16
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Published in Journal of hepatology (01-01-2017)“…Graphical abstract…”
Get full text
Journal Article -
17
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study
Published in Journal of hepatology (01-10-2016)“…Graphical abstract…”
Get full text
Journal Article -
18
Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure
Published in Antiviral research (01-08-2021)“…Entecavir treatment failure can be observed in compliant patients despite an absence of detectable resistance mutations by Pol/RT Sanger sequencing. We…”
Get full text
Journal Article -
19
Revisiting HBV resistance to entecavir with a phenotypic approach
Published in Antiviral research (01-09-2020)“…Treatment adaptation after hepatitis B virus (HBV) treatment failure relies on genotypic resistance testing. However, the results of such tests are not always…”
Get full text
Journal Article -
20
Reply to: “Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials?”
Published in Journal of hepatology (01-01-2015)Get full text
Journal Article